No Cafe I’m not. Cash burn is an issue for a lot of bio companies on the ASX. But not many have at least a product they can sell. Oncosil is one of a very few that has that ability. Sure, it has been frustrating and slow but at least it has a CE approval and is in use and being sold. Plenty of bio companies with zero sales, and costly cash burning trials.
Rights Issue, page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $303.5K | 25.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 9786329 | 8 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |